Researchers from Rutgers Cancer Institute, with RWJBarnabas Health and in collaboration with investigators from MD Anderson, discovered a novel triple immunotherapy combination, targeting checkpoints on both T cells and myeloid suppressor cells, that dramatically improved anti-tumor responses by reprogramming the tumor microenvironment in preclinical models of PDAC.
During September-December 2022, the Pre2 CAP (Precision Prevention of Prostate Cancer) Laboratory contributed to scientific knowledge on multilevel strategies for reducing burden of prostate cancer in diverse populations. Dr. Iyer presented preliminary work on associations between prostate tumor tissue markers of inflammation and neighborhood environments at the International Society of Environmental Epidemiology in Athens, Greece. He also presented on work of the Pre2 CAP lab at local meetings of the Community Health Advisory Board and Science Cafes.
Jennifer Falcon
Administrative Research Associate
jf1212@cinj.rutgers.edu
Jesminara Khatun
Postdoctoral Fellow 2022-2023
Current Position: Postdoctoral fellow at Icahn School of Medicine at Mt. Sinai
Luca Tottone
Postdoctoral Fellow 2018-2022
Current Position: Assistant Scientist at University of Miami
Olga Lancho
Postdoctoral Fellow 2017-2022
Current Position: Principal Scientist in Cell Banking at Eurofins
Patricia Renck Nunes
Postdoctoral Fellow 2020-2022
Current Position: Scientific Writer at Bristol Myers Squibb
Susan P. Fenker, MS, LCSW
fenkersp@cinj.rutgers.edu
Sara Frederick
sf503@cinj.rutgers.edu
Marissa Grosso
mag493@cinj.rutgers.edu
Sharon Manne, PhD, is a Professor of Medicine and Director of the Joint Office for Faculty Mentorship at Rutgers Cancer Institute and Rutgers Robert Wood Johnson Medical School. She is also a founding co-director of the Cancer Survivorship and Outcomes Center at Rutgers Cancer Institute. A clinical psychologist, Dr.
